Peripheral Arterial Disease Biomarkers
ConditionPeripheral Arterial Disease
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age50-99
SponsorNorfolk and Norwich University Hospitals NHS Foundation Trust
The study aims to determine how expression levels of biomarkers for peripheral arterial disease change over time in response to exercise therapy, surgical or endovascular intervention, and whether they can be used to predict disease progression.
Aged > 50 years
Symptomatic PAD
ABPI <0.8 or TBPI <0.7
Aged <50 years
Current Malignancy
Rheumatological Condition
Previous surgical or endovascular intervention for PAD